GRAF JAMES A (Chief Executive Officer) purchased 0.0% of their position (1.30K shares) of NKGEN BIOTECH, INC. on the open market
Open‑market purchase worth $12.9K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 5/25/2021ACC: 0001104659-21-071966
Officer10% Owner· Chief Executive Officer
Since May 2021
+1.30K
Net shares
Net buyer
$12.9K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
1.30K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+1.05K
Price / share
$9.95
Trade value
$10.45K
% of position
0.0%
5/21/2021
4.25M→4.25M
Common Stock
Direct
Shares
+28.00
Price / share
$9.94
Trade value
$278.32
% of position
0.0%
5/24/2021
4.25M→4.25M
Common Stock
Direct
Shares
+222.00
Price / share
$9.90
Trade value
$2.20K
% of position
0.0%
5/25/2021
4.25M→4.25M
Total
Net shares
+1.30K
Net value
$12.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/21/2021 | P · Purchase | +1.05K | $9.95 | $10.45K | 0.0% | 4.25M | 4.25M |
| Common Stock Direct | 5/24/2021 | P · Purchase | +28.00 | $9.94 | $278.32 | 0.0% | 4.25M | 4.25M |
| Common Stock Direct | 5/25/2021 | P · Purchase | +222.00 | $9.90 | $2.20K | 0.0% | 4.25M | 4.25M |
| Total | +1.30K | $12.92K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned4.25M
Total
4.25M indirect4.25M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.25M | Indirect |
| Total | 4.25M | 4.25M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported